The new drug candidate, developed by the Farzan lab and colleagues, has been effective against all strains of HIV tested.
A $1.4-million grant will enable the Lasmézas lab to follow up the findings with a search for drug candidates.
A new study from the Schultz lab could help people with growth disorders and other conditions.
A study from the Ja lab sheds new light on a surprising and critical role that microbes may play in nutritional disorders such as protein malnutrition.
Patrick Griffin, Linda Sherman and Edward Sanderson join the Board.